Clinical trial
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's…
NCT00096538 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00096538 |
|---|---|
| Title | Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma |
| Official title | Pilot Study Of Valganciclovir In Patients With Classic, Non-HIV-Associated Kaposi's Sarcoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH New York Presbyterian Hospital Weill Medical College of Cornell University University of North Carolina, Chapel Hill |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | valganciclovir |
| Enrollment | 6 |
| Start date | Apr 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Nov 10, 2004 |
| Last update posted | Nov 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: